Our hosting provider is investigating network issues. We apologize for the inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Nature immunology | Feb 28, 2002

The imidazoquinoline compounds imiquimod and R-848 are low-molecular-weight immune response modifiers that can induce the synthesis of interferon-alpha and other cytokines in a variety of cell types. These compounds have potent anti-viral and anti-tumor properties; however, the mechanisms by which they exert their anti-viral activities remain unclear. Here we show that the imidazoquinolines activate immune cells via the Toll-like receptor 7 (TLR7)-MyD88-dependent signaling pathway. In response to the imidazoquinolines, neither MyD88- nor TLR7-deficient mice showed any inflammatory cytokine production by macrophages, proliferation of splenocytes or maturation of dendritic cells. Imidazoquinoline-induced signaling events were also abolished in both MyD88- and TLR7-deficient mice.

Pubmed ID: 11812998 RIS Download

Mesh terms: Adaptor Proteins, Signal Transducing | Adjuvants, Immunologic | Aminoquinolines | Animals | Antigens, Differentiation | Antiviral Agents | Bone Marrow Cells | Dendritic Cells | Drosophila Proteins | Imidazoles | Interferon Inducers | Macrophages, Peritoneal | Membrane Glycoproteins | Mice | Mice, Mutant Strains | Myeloid Differentiation Factor 88 | Receptors, Cell Surface | Receptors, Immunologic | Spleen | Toll-Like Receptor 7 | Toll-Like Receptors

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.